Table 6
| n = 58 | |
|---|---|
| Ever smoked, n (%) | 29 (53) |
| Pack years | 1 (0; 25) |
| Medication data | |
| Erythropoietin (units/week) | 6000 (1000; 9000) |
| Intravenous iron (mg/week) | 0.0 (0.0–50.0) |
| ACE inhibitors, n (%) | 5 (8.6) |
| ARB, n (%) | 7 (12.1) |
| Beta-blockers, n (%) | 26 (44.8) |
| Statins, n (%) | 35 (60.3) |
| Calcium-channel blockers, n (%) | 27 (46.6) |
| Diuretics, n (%) | 17 (29.3) |
| Alpha blockers, n (%) | 11 (19.0) |
| Aspirin, n (%) | 24 (41.4) |
| Insulin, n (%) | 14 (24.1) |
| Oral hypoglycaemic, n (%) | 6 (1.0) |
| Haematological and biochemical data | |
| Sodium (mmol/L) | 136.6 ± 3.2 |
| Potassium (mmol/L) | 5.0 ± 0.9 |
| Bicarbonate (mmol(L) | 25.3 ± 3.0 |
| Phosphate (mmol/L) | 1.5 (1.3; 2.0) |
| Calcium (mmol/L) | 2.3 ± 0.2 |
| Urea reduction ratio (%) | 76.5 (70.8; 81.3) |
| Haemoglobin (g/L) | 111.5 (99.0; 123.0) |
| Total cholesterol (mmol/L) [n = 45] | 3.8 (3.0; 4.5) |
| HbA1c (%) [n = 43] | 5.8 (5.1; 7.2) |
| WCC (109/L) | 6.3 (5.3; 8.8) |
| Platelets (109/L) | 215.3 ± 82.8 |
| Albumin (g/L) | 36.8 ± 5.2 |
| Ferritin (ng/ml) [n = 57] | 278 (176; 403) |
| CRP detectable (≥5) [n = 45] | 22 |
| CRP (mg/L) [n = 22] | 18 (12; 36) |
| PTH [n = 37] | 49 (17; 82) |
Categorical variables presented as number (%). Normally distributed data presented as mean ± SD. Non-normally distributed data presented as median (P25, 75)
ACE Angiotensin-converting-enzyme, ARB Angiotensin-receptor blocker, BMI Body mass index, CRP C-reactive protein, HbA1c Glycosylated haemoglobin, PTH Parathyroid hormone, WCC White cell count